Physician profile
Daoling Zhang
NPI 1003922485
$2,161.22
in general payments reported to CMS, 2019-2025
19 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $255 · 2021: $225 · 2022: $361 · 2023: $530 · 2024: $360 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.59 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $576.81 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| New World Medical,INC. | $230.16 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $216.63 | 2020-2021 | |
| Glaukos Corporation | $182.63 | 2022-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite, Idosetr |
| Bausch & Lomb Americas INC. | $169.34 | 2022-2025 | Miebo, Scoutpro Osmolarity System, Vyzulta |
| Aerie Pharmaceuticals, INC. | $131.07 | 2019-2021 | |
| Allergan, INC. | $125.00 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $94.39 | 2019-2021 | |
| Alcon Vision LLC | $91.29 | 2021-2025 | Rocklatan, Tryptyr |
| Oyster Point Pharma, INC. | $69.83 | 2022-2025 | Ryzumvi, Tyrvaya |
| Horizon Therapeutics Plc | $67.99 | 2020-2022 | |
| Amgen INC. | $50.68 | 2024-2025 | Tepezza |
| Mallinckrodt Enterprises LLC | $40.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.94 | 2019 | |
| Thea Pharma INC. | $23.19 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $19.58 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Shire North American Group INC | $18.22 | 2019 | |
| Ocular Therapeutix, INC. | $15.41 | 2020 | |
| Kala Pharmaceuticals, INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daoling Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.